Catherine Stehman-Breen, M.D.

Catherine Stehman-Breen, M.D.

DirectoratDyne Therapeutics· In proxies 2023–2025

Catherine Stehman-Breen, M.D. sits on 4 public boards.

Boards2

  • Tenaya TherapeuticsDirector · 5 yr on the boardIndependentScience and Technology (Chair)—Paid as an executive
  • Dyne TherapeuticsDirector · 4 yr on the boardIndependentAudit, Research and Development—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Dyne TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +51%
  2. Tenaya TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Generation Bio Co.Public company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  4. Tenaya Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?